Having trouble viewing this e-mail? Click here

ModernMedicine/Physician's Focus
Androgen Deprivation Therapy for Prostate Cancer

ModernMedicine provides predictive tools to help pinpoint those patients for whom the therapy is likely to be most beneficial and data on regimen timing to mitigate risks.

Covered in the Physician�s Focus:

  • Baseline testosterone/BMI ratio predicts which patients gain from androgen deprivation therapy
  • Androgen receptor activity suggests androgen deprivation therapy response
  • Intermittent androgen deprivation therapy limits side effects, improves quality of life

Click here to access these resources…

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.